Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference

DALLAS and FORT WORTH, Texas, March 06, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. NEOS, a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally disintegrating tablet (ODT) technology platforms, today announced that Jerry McLaughlin, Chief Executive Officer of Neos Therapeutics, will present a company overview at the upcoming Cowen & Co. 39th Annual Health Care Conference on Wednesday, March 13, 2019 at 11:20 a.m. ET in Boston, MA.

A live webcast of the presentation will be available on the Investor Relations page of the company's website at http://investors.neostx.com/. Following the presentation, a replay of the webcast will be available on Neos' website for 30 days. 

About Neos Therapeutics

Neos Therapeutics, Inc. NEOS is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING), Cotempla XR-ODT® (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING), and Adzenys-ER™ (amphetamine) extended-release oral suspension (see Full Prescribing Information, including Boxed WARNING), all for the treatment of ADHD, are three approved products using the Company's extended-release  technology platform. Additional information about Neos is available at www.neostx.com.

CONTACTS:

Richard I. Eisenstadt

Chief Financial Officer

Neos Therapeutics

(972) 408-1389

reisenstadt@neostx.com

Sarah McCabe

Investor Relations

Stern Investor Relations, Inc.

(212) 362-1200

sarah.mccabe@sternir.com

Neos Therapeutics logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!